Derrick Sung

Derrick Sung

Director Financiero/CFO en PULMONX CORPORATION .

Fortuna: 258 459 $ al 30/09/2026

53 años
Health Technology
Consumer Services
Finance

Perfil

Derrick Sung is currently Director at Sensydia Corp.
since 2018, Chief Financial Officer at Aerin Medical, Inc. since 2023, and Chief Operating & Financial Officer at Pulmonx Corp.
starting in 2025.
Former positions include Director-Marketing & Business Development at Boston Scientific Corp.
from 2004 to 2008, Independent Director at Minerva Surgical, Inc. from 2022 to 2024, Chief Financial & Accounting Officer at Pulmonx Corp.
from 2019 to 2023, Executive VP-Strategy & Corporate Development at iRhythm Holdings, Inc. from 2015 to 2019, Senior Research Analyst at Sanford C.
Bernstein & Co. LLC from 2008 to 2014, Principal at Vascular Intervention, and Principal at The Boston Consulting Group, Inc. from 2000 to 2004.
Education includes undergraduate studies at Stanford University, an MBA from San Diego State University, and a doctorate from the University of California San Diego.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
15/03/2026 135.319 ( 0,32 % ) 258 459 $ 30/09/2026

Cargos activos de Derrick Sung

EmpresasCargoInicio
PULMONX CORPORATION Director Financiero/CFO 03/11/2025
Director Financiero/CFO 20/11/2023
Director/Miembro de la Junta 01/08/2018

Antiguos cargos conocidos de Derrick Sung.

EmpresasCargoFin
MINERVA SURGICAL, INC. Director/Miembro de la Junta 01/01/2024
PULMONX CORPORATION Director Financiero/CFO 10/10/2023
IRHYTHM HOLDINGS, INC. Corporate Officer/Principal 01/05/2019
BOSTON SCIENTIFIC CORPORATION Ventas & Marketing 01/01/2008
Corporate Officer/Principal 01/01/2004
Ver el detalle de la experiencia de Derrick Sung.

Formación de Derrick Sung.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

70

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Finance

Consumer Services

Consumer Services

Vascular Intervention

Finance